Funding agencies: National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford University Hospitals NHS Trust and the University of Oxford (to Y.H., P.W., and A.V.); NHS Specialized Services for Rare Diseases (neuromyelitis optica; to P.W. and A.V.).
N-methyl-D-aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse
Article first published online: 6 SEP 2013
Copyright © 2013 Movement Disorder Society
Volume 29, Issue 1, pages 90–96, January 2014
How to Cite
Hacohen, Y., Deiva, K., Pettingill, P., Waters, P., Siddiqui, A., Chretien, P., Menson, E., Lin, J.-P., Tardieu, M., Vincent, A. and Lim, M. J. (2014), N-methyl-D-aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse. Mov. Disord., 29: 90–96. doi: 10.1002/mds.25626
Relevant conflicts of interest/financial disclosures: AV and the University of Oxford, hold patents and receive royalties and payments for antibody assays in neurologic diseases.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 23 JAN 2014
- Article first published online: 6 SEP 2013
- Manuscript Accepted: 1 JUL 2013
- Manuscript Revised: 5 JUN 2013
- Manuscript Received: 13 FEB 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.